CHATTANOOGA, Tenn.– EirSystems, an emerging leader in software development for prescribing and distributing prescriptions safely and efficiently, recently closed a seed funding round led by Solas BioVentures. Additional investors included several Chain Reaction Boston investors led by Ken Mooney. With this funding, EirSystems will continue to secure partnerships and grow market share in the e-prescribing market.
“EirSystems’ innovation in the e-prescription market is second to none. This technology will help physicians better serve their patients’ wellbeing with faster and more accurate information at hand,” commented David Adair, MD, M.B.A., Co-Founder and Managing Director of Solas BioVentures. “We fully support their growth and look forward to the company’s future.”
“We are delighted to co-invest with Solas BioVentures in this round of financing for EirSystems,” said Eliza Petrow, Managing Director at Chain Reaction Boston. “At Chain Reaction, our group of angel investors is focused on funding innovative blockchain-based solutions, including in the healthcare space, and EirSystems fits that profile nicely.”
“We are incredibly grateful to work with Solas BioVentures and Chain Reaction to secure our latest funding round. We believe our partnership with Solas will allow EirSystems to make more partnerships in the healthcare industry, allowing our product to grow quickly over the next few years,” stated EirSystems CEO Tyler Seaberg. “Specifically, this funding will enable us to ramp up production, expand our support teams by hiring talent from the Chattanooga area and, in 2023, release new product offerings for medication management and prescription drug claims designed to impact the prescribing space significantly.”
EirSystems’ proprietary P.A.G.R. (Prescription Abuse Greatly Reduced) is an advanced software platform providing physicians and pharmacists the tools they need to make the prescribing process simple, safe, and efficient for their patients. P.A.G.R. can be integrated or installed into any system and operates in one easy-to-use web interface.
